Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology

The authors review the effects of prolonged IV-PGI(2) administration in severely ill adolescents and adults with Eisenmenger physiology, comparing baseline characteristics with data collected after 3 months of therapy.

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2003-03, Vol.91 (5), p.632-635
Main Authors: Fernandes, Susan M., Newburger, Jane W., Lang, Peter, Pearson, Dorothy D., Feinstein, Jeffrey A., Gauvreau, Kimberlee, Landzberg, Michael J.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Biological and medical sciences
Cardiac Catheterization
Cardiovascular system
Critical Illness
Disease
Dose-Response Relationship, Drug
Drug Administration Schedule
Effects
Eisenmenger Complex - diagnosis
Eisenmenger Complex - drug therapy
Electrocardiography
Epoprostenol - administration & dosage
Female
Follow-Up Studies
Heart Function Tests
Hemodynamics - physiology
Humans
Infusions, Intravenous
Male
Medical sciences
Middle Aged
Oxygen Consumption
Pharmacology. Drug treatments
Retrospective Studies
Risk Assessment
Therapy
Treatment Outcome
Vasodilator agents. Cerebral vasodilators
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The authors review the effects of prolonged IV-PGI(2) administration in severely ill adolescents and adults with Eisenmenger physiology, comparing baseline characteristics with data collected after 3 months of therapy.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(02)03328-3